BioSpace News Archive

Webcast scheduled for Wednesday, May 6 at 11:30 a.m. Eastern Time

Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced it has appointed Matthew Gibbs, PharmD, as President of Commercial Markets.

Companies’ holistic approach to digestive health combines pharmaceuticals with health interventions via digital platform to help cope with complex conditions BERLIN--( BUSINESS WIRE )-- Digital health company HiDoc Technologies GmbH, dba Cara Care , has teamed up with the Consumer Healthcare Business Unit of Sanofi Germany on a holistic approach to digestive health that bundles Sanofi’s Buscomint ® bei Reizdarm pharmaceutical drug with Cara Care

Lupin Pharmaceuticals Inc. (Lupin), the U.S. based wholly owned subsidiary of Lupin Limited, announced today that Solosec ® (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women has received preferred coverage effective immediately on the Express Scripts National Preferred, Flex,

Co-primary endpoints met with 75.2% response rate for dysmenorrhea (menstrual pain) (p < 0.0001) and 66.0% response rate for non-menstrual pelvic pain (p < 0.0001) Women receiving relugolix combination therapy, on average, had a 75.1% reduction on the Numerical Rating Scale for dysmenorrhea from 7.2 (severe pain) to 1.7 (mild pain) Achieved six key secondary endpoints, including improvement in impact of pain on daily activities and a greater proportion of women not using opioids

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 7, 2020, at 4:30 p.m. EDT to discuss its financial results for the fiscal second quarter ended March 31, 2020. Conference Call and Webcast Details Investors may access a live audio webcast on the Company’s website at http://ir.arrowheadpharma.com/events.cfm . For analysts that wish to partic

OPKO Health, Inc. provided an update on two abstracts regarding the global Phase 3 somatrogon pediatric trial evaluating somatrogon dosed once weekly in pre-pubertal children with growth hormone deficiency.

CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced that it had filed a Shelf Registration Statement on Form S-3 with the Securities and Exchange Commission on April 21, 2020.

SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced it will report financial results for the first quarter of 2020 after market close on Monday, May 4, 2020.

Statistically significant primary efficacy endpoint of reduction in weekly-average Worst-Itch Numeric Rating Scale (WI-NRS) at Week 8